Shamburg News · 8-K filed Nov 12, 2026, 4:15 PM EST

VolitionRx Reports Third Quarter 2026 Results; Revenue Rises 157% to $1.6 Million

VNRX · VOLITIONRX LTD

  • Earnings
  • Materiality: high

VolitionRx Limited issued a press release on November 12, 2026 announcing financial results and a business update for the quarter ended September 30, 2026. The company reported third quarter 2026 revenue of approximately $1.6 million, up 157% from $0.6 million a year earlier, and a net loss of $3.8 million compared with $5.4 million in the prior-year period. Cash and cash equivalents totaled approximately $2.4 million as of September 30, 2026, and the company prepaid its outstanding $7.5 million convertible note in cash during the quarter.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001477932-26-006879.

Written from the filing by Shamburg Markets. Figures are as reported by the company.